WASHINGTON, D.C. – Rep. Edward J. Markey (D-MA), a senior member of the House Energy and Commerce Committee, applauded the expected passage of legislation that will make the most sweeping safety and regulatory changes to the Food and Drug Administration in years. He spoke on the House Floor in support of langauge he helped write in the bill to establish public databases of clinical trials and their results. For more information click here.